Metabolic activation of islet cells improves resistance against oxygen radicals or streptozocin, but not nitric oxide

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3966-3971

  Burkart, V ^a,b   Brenner, H H ^a   Hartmann, B ^a   Kolb, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GLIBENCLAMIDE; GLUCOSE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; STREPTOZOCIN; THEOPHYLLINE DERIVATIVE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL MEMBRANE RESISTANCE; CONTROLLED STUDY; DOSE RESPONSE; ETIOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MEMBRANE BINDING; MITOCHONDRIAL RESPIRATION; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DRUG RESISTANCE; FREE RADICALS; GLUCOSE; GLYBURIDE; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; NITRIC OXIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; THEOPHYLLINE;

ANIMALIA;

EID: 0029836903     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3966     Document Type: Article

References (50)

1. Eisenbarth G. 1986 Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med. 314:1360-1368.
2. Kolb H, Burkart V, Appels B, et al. 1990 Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmunity. 3(Suppl):117-120.
3. Buschard K. 1991 The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Autoimmunity. 10:65-69.
4. Dunger A, Schröder D, Augstein P, et al. 1995 Impact of metabolic activity of beta cells on cytokines-induced damage and recovery of rat pancreatic islets. Acta Diabetol. 32:217-224.
5. Shah SC, Malone JI, Simpson NE. 1989 A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med. 320:550-554.
6. Godtfredsen CF, Buschard K, Frandsen EK. 1985 Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia. 28:933-935.
7. Atkinson MA, MacLaren NK, Luchetta R. 1990 Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:933-937.
8. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG. 1982 Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci USA. 79:927-930.
9. Jarasch E-D, Bruder G, Heid HW. 1986 Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand. 548(Suppl):39-46.
10. Zweier JI, Kuppusamy P, Lutty GA. 1994 Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischaemic tissues. Proc Natl Acad Sci USA. 85:4046-4050.
11. Babior B. 1984 The respiratory burst of phagocytes. J Clin Invest. 73:599-601.
12. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. 1989 Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia. 32:126-134.
13. Brenner H-H, Burkart V, Rothe H, Kolb H. 1993 Oxygen radical production is increased in macrophages from diabetes prone BB rats. Autoimmunity, 15:93-98.
14. Wu G, Marliss EB. 1993 Enhanced glucose metabolism and respiratory burst in peritoneal macrophages from spontaneously diabetic BB rats. Diabetes. 42:520-529.
15. Ischiropoulos H, Zhu L, Beckman JS. 1992 Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 298:446-451.
16. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990 Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1620-1624.
17. Kröncke K-D, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. 1991 Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun. 175:752-758.
18. Appels B, Burkart V, Kantwerk-Funke G, Funda J, Kolb-Bachofen V, Kolb H. 1989 Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol. 142:3803-3808.
19. Burkart V, Koike T, Brenner H-H, Kolb H. 1992 Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro. Diabetologia. 35:1028-1034.
20. Kallmann B, Burkart V, Kröncke K-D, Kolb-Bachofen V, Kolb H. 1992 Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51:671-678.
21. Mosmann T. 1983 Rapid colorimetric assay tor cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55-63.
22. Janjic D, Wollheim CB. 1992 Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia. 35:482-485.
23. Eizirik DL, Strandell E, Sandier S. 1988 Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia. 31:168-174.
24. Pipeleers D, Van De Winkel M. 1986 Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA. 83: 5267-5271.
25. Park B-H, Rho H-W, Park J-W, et al. 1995 Protective mechanism of glucose against alloxan-induced pancreatic β-cell damage. Biochem Biophys Res Commun. 210:1-6.
26. Sener M, Malaisse WJ. 1987 Stimulation by D-glucose of mitochondrial oxidative events in islet cells. Biochem J. 246:89-95.
27. + channel in insulin-secreting cells. J Biol Chem. 262:15840-15844.
28. Müller G, Hartz D, Pünter J, Ökonomopulos R, Kramer W. 1994 Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta. 1191:267-277.
29. + uniports and exchangers. J Bioenerg Biomembr. 26:519-526.
30. + fluxes in rat liver mitochondria. Biochem Mol Biol Int. 33:165-175.
31. Wang LJ, Corbett JA, Marshall CA, McDaniel ML. 1993 Glucose-induced insulin secretion from purified β-cells. J Biol Chem. 11:7785-7791.
32. Ghosh SK, Poddar MK. 1993 δ-9-Tetrahydrocannabinol inhibits binding of theophylline to mammalian neuronal and non-neuronal membranes. Biochem Pharmacol. 45:1725-1728.
33. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H. 1982 Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem. 257:6084-6088.
34. + depletion. Biochem Biophys Res Commun. 199:1270-1277.
35. Heller B, Wang Z-Q, Wagner E, et al. 1995 Inactivation of the poly(ADP-ribose)polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem. 270:11176-11180.
36. Wang Z, Gleichmann H. 1995 Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-d-glucose. Exp Clin Endocrinol. 103:83-87.
37. Schnedl WJ, Ferber S, Johnson J, Newgard CB. 1994 STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes. 43:1326-1333.
38. Sandier S, Welsh M, Andersson A. 1983 Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase. Acta Pharmacol Toxicol. 53:392-400.
39. Tramper J. 1987 Preparation of immobilized milk xanthine oxidase and application in organic systems. In: Mosbach K, ed. Methods in enzymology. London: Academic Press; vol 136:254-262.
40. Moncada S, Palmer RMJ, Higgs EA. 1991 Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:109-142.
41. Kolb H, Kolb-Bachofen V. 1992 Nitric oxide: a pathogenetic factor in autoimmunity, Immunol Today. 13:157-160.
42. Corbett JA, Wang JL, Hughes JH, et al. 1992 Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J. 287:229-235.
43. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML. 1993 Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA. 90:1731-1735.
44. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I. 1992 Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia. 35:409-413.
45. Yamada K, Inada C, Otabe S, Takane N, Hayashi H, Nonaka K. 1993 Effects of free radical scavengers on cytokine actions on islet cells. Acta Endocrinol (Copenh). 128:379-384.
46. Andersen HU, Jorgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J. 1994 Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes. 43:770-777.
47. Williams AJK, Beales PE, Krug J, et al. 1993 Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. Diabetologia. 36:487-492.
48. Hosszufalusi N, Reinherz L, Takei S, Chan E, Charles MA. 1995 Glipizide-induced prevention of diabetes and autoimmune events in the BB rat. J Autoimmunity. 7:753-761.
49. Rabinovitch A, Sumoski WL. 1990 Theophylline protects against diabetes in BB rats and potentiates cyclosporine protection. Diabetologia. 33:506-508.
50. Bösing-Schneider R, Kolb H. 1973 Influence of cyclic AMP on early events of the immune induction. Nature. 244:224-225.